[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Prostate Cancer Medicine Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

September 2023 | 111 pages | ID: G5E72BCA7F98EN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question


The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Prostate Cancer Medicine market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Prostate Cancer Medicine market are covered in Chapter 9:

Bristol Myers-Squibb
Bayer AG
Johnson & Johnson
Astellas Pharma Inc.
Pfizer Inc.
Active Biotech
Abbott Laboratories
Teva Pharmaceuticals Industries Ltd.
Roche Holding AG
AstraZeneca plc

In Chapter 5 and Chapter 7.3, based on types, the Prostate Cancer Medicine market from 2017 to 2027 is primarily split into:

LHRH Antagonists
LHRH Analogs
Antiandrogens
Pipeline Drugs for Hormonal Therapy


In Chapter 6 and Chapter 7.4, based on applications, the Prostate Cancer Medicine market from 2017 to 2027 covers:

Hospitals
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Client Focus

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Prostate Cancer Medicine market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Prostate Cancer Medicine Industry.

2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Please find the key player list in Summary.

3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline

Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2027

1 PROSTATE CANCER MEDICINE MARKET OVERVIEW

1.1 Product Overview and Scope of Prostate Cancer Medicine Market
1.2 Prostate Cancer Medicine Market Segment by Type
  1.2.1 Global Prostate Cancer Medicine Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Prostate Cancer Medicine Market Segment by Application
  1.3.1 Prostate Cancer Medicine Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Prostate Cancer Medicine Market, Region Wise (2017-2027)
  1.4.1 Global Prostate Cancer Medicine Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Prostate Cancer Medicine Market Status and Prospect (2017-2027)
  1.4.3 Europe Prostate Cancer Medicine Market Status and Prospect (2017-2027)
  1.4.4 China Prostate Cancer Medicine Market Status and Prospect (2017-2027)
  1.4.5 Japan Prostate Cancer Medicine Market Status and Prospect (2017-2027)
  1.4.6 India Prostate Cancer Medicine Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Prostate Cancer Medicine Market Status and Prospect (2017-2027)
  1.4.8 Latin America Prostate Cancer Medicine Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Prostate Cancer Medicine Market Status and Prospect (2017-2027)
1.5 Global Market Size of Prostate Cancer Medicine (2017-2027)
  1.5.1 Global Prostate Cancer Medicine Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Prostate Cancer Medicine Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Prostate Cancer Medicine Market

2 INDUSTRY OUTLOOK

2.1 Prostate Cancer Medicine Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Prostate Cancer Medicine Market Drivers Analysis
2.4 Prostate Cancer Medicine Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Prostate Cancer Medicine Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Prostate Cancer Medicine Industry Development

3 GLOBAL PROSTATE CANCER MEDICINE MARKET LANDSCAPE BY PLAYER

3.1 Global Prostate Cancer Medicine Sales Volume and Share by Player (2017-2022)
3.2 Global Prostate Cancer Medicine Revenue and Market Share by Player (2017-2022)
3.3 Global Prostate Cancer Medicine Average Price by Player (2017-2022)
3.4 Global Prostate Cancer Medicine Gross Margin by Player (2017-2022)
3.5 Prostate Cancer Medicine Market Competitive Situation and Trends
  3.5.1 Prostate Cancer Medicine Market Concentration Rate
  3.5.2 Prostate Cancer Medicine Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL PROSTATE CANCER MEDICINE SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Prostate Cancer Medicine Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Prostate Cancer Medicine Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Prostate Cancer Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Prostate Cancer Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Prostate Cancer Medicine Market Under COVID-19
4.5 Europe Prostate Cancer Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Prostate Cancer Medicine Market Under COVID-19
4.6 China Prostate Cancer Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Prostate Cancer Medicine Market Under COVID-19
4.7 Japan Prostate Cancer Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Prostate Cancer Medicine Market Under COVID-19
4.8 India Prostate Cancer Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Prostate Cancer Medicine Market Under COVID-19
4.9 Southeast Asia Prostate Cancer Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Prostate Cancer Medicine Market Under COVID-19
4.10 Latin America Prostate Cancer Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Prostate Cancer Medicine Market Under COVID-19
4.11 Middle East and Africa Prostate Cancer Medicine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Prostate Cancer Medicine Market Under COVID-19

5 GLOBAL PROSTATE CANCER MEDICINE SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Prostate Cancer Medicine Sales Volume and Market Share by Type (2017-2022)
5.2 Global Prostate Cancer Medicine Revenue and Market Share by Type (2017-2022)
5.3 Global Prostate Cancer Medicine Price by Type (2017-2022)
5.4 Global Prostate Cancer Medicine Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Prostate Cancer Medicine Sales Volume, Revenue and Growth Rate of LHRH Antagonists (2017-2022)
  5.4.2 Global Prostate Cancer Medicine Sales Volume, Revenue and Growth Rate of LHRH Analogs (2017-2022)
  5.4.3 Global Prostate Cancer Medicine Sales Volume, Revenue and Growth Rate of Antiandrogens (2017-2022)
  5.4.4 Global Prostate Cancer Medicine Sales Volume, Revenue and Growth Rate of Pipeline Drugs for Hormonal Therapy (2017-2022)

6 GLOBAL PROSTATE CANCER MEDICINE MARKET ANALYSIS BY APPLICATION

6.1 Global Prostate Cancer Medicine Consumption and Market Share by Application (2017-2022)
6.2 Global Prostate Cancer Medicine Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Prostate Cancer Medicine Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Prostate Cancer Medicine Consumption and Growth Rate of Hospitals (2017-2022)
  6.3.2 Global Prostate Cancer Medicine Consumption and Growth Rate of Other (2017-2022)

7 GLOBAL PROSTATE CANCER MEDICINE MARKET FORECAST (2022-2027)

7.1 Global Prostate Cancer Medicine Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Prostate Cancer Medicine Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Prostate Cancer Medicine Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Prostate Cancer Medicine Price and Trend Forecast (2022-2027)
7.2 Global Prostate Cancer Medicine Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Prostate Cancer Medicine Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Prostate Cancer Medicine Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Prostate Cancer Medicine Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Prostate Cancer Medicine Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Prostate Cancer Medicine Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Prostate Cancer Medicine Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Prostate Cancer Medicine Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Prostate Cancer Medicine Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Prostate Cancer Medicine Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Prostate Cancer Medicine Revenue and Growth Rate of LHRH Antagonists (2022-2027)
  7.3.2 Global Prostate Cancer Medicine Revenue and Growth Rate of LHRH Analogs (2022-2027)
  7.3.3 Global Prostate Cancer Medicine Revenue and Growth Rate of Antiandrogens (2022-2027)
  7.3.4 Global Prostate Cancer Medicine Revenue and Growth Rate of Pipeline Drugs for Hormonal Therapy (2022-2027)
7.4 Global Prostate Cancer Medicine Consumption Forecast by Application (2022-2027)
  7.4.1 Global Prostate Cancer Medicine Consumption Value and Growth Rate of Hospitals(2022-2027)
  7.4.2 Global Prostate Cancer Medicine Consumption Value and Growth Rate of Other(2022-2027)
7.5 Prostate Cancer Medicine Market Forecast Under COVID-19

8 PROSTATE CANCER MEDICINE MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Prostate Cancer Medicine Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Prostate Cancer Medicine Analysis
8.6 Major Downstream Buyers of Prostate Cancer Medicine Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Prostate Cancer Medicine Industry

9 PLAYERS PROFILES

9.1 Bristol Myers-Squibb
  9.1.1 Bristol Myers-Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Prostate Cancer Medicine Product Profiles, Application and Specification
  9.1.3 Bristol Myers-Squibb Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Bayer AG
  9.2.1 Bayer AG Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Prostate Cancer Medicine Product Profiles, Application and Specification
  9.2.3 Bayer AG Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Johnson & Johnson
  9.3.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Prostate Cancer Medicine Product Profiles, Application and Specification
  9.3.3 Johnson & Johnson Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Astellas Pharma Inc.
  9.4.1 Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Prostate Cancer Medicine Product Profiles, Application and Specification
  9.4.3 Astellas Pharma Inc. Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Pfizer Inc.
  9.5.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Prostate Cancer Medicine Product Profiles, Application and Specification
  9.5.3 Pfizer Inc. Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Active Biotech
  9.6.1 Active Biotech Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Prostate Cancer Medicine Product Profiles, Application and Specification
  9.6.3 Active Biotech Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Abbott Laboratories
  9.7.1 Abbott Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Prostate Cancer Medicine Product Profiles, Application and Specification
  9.7.3 Abbott Laboratories Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Teva Pharmaceuticals Industries Ltd.
  9.8.1 Teva Pharmaceuticals Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Prostate Cancer Medicine Product Profiles, Application and Specification
  9.8.3 Teva Pharmaceuticals Industries Ltd. Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Roche Holding AG
  9.9.1 Roche Holding AG Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Prostate Cancer Medicine Product Profiles, Application and Specification
  9.9.3 Roche Holding AG Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 AstraZeneca plc
  9.10.1 AstraZeneca plc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Prostate Cancer Medicine Product Profiles, Application and Specification
  9.10.3 AstraZeneca plc Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION


11 APPENDIX

11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES

Figure Prostate Cancer Medicine Product Picture
Table Global Prostate Cancer Medicine Market Sales Volume and CAGR (%) Comparison by Type
Table Prostate Cancer Medicine Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Prostate Cancer Medicine Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Prostate Cancer Medicine Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Prostate Cancer Medicine Industry Development
Table Global Prostate Cancer Medicine Sales Volume by Player (2017-2022)
Table Global Prostate Cancer Medicine Sales Volume Share by Player (2017-2022)
Figure Global Prostate Cancer Medicine Sales Volume Share by Player in 2021
Table Prostate Cancer Medicine Revenue (Million USD) by Player (2017-2022)
Table Prostate Cancer Medicine Revenue Market Share by Player (2017-2022)
Table Prostate Cancer Medicine Price by Player (2017-2022)
Table Prostate Cancer Medicine Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Prostate Cancer Medicine Sales Volume, Region Wise (2017-2022)
Table Global Prostate Cancer Medicine Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Prostate Cancer Medicine Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Prostate Cancer Medicine Sales Volume Market Share, Region Wise in 2021
Table Global Prostate Cancer Medicine Revenue (Million USD), Region Wise (2017-2022)
Table Global Prostate Cancer Medicine Revenue Market Share, Region Wise (2017-2022)
Figure Global Prostate Cancer Medicine Revenue Market Share, Region Wise (2017-2022)
Figure Global Prostate Cancer Medicine Revenue Market Share, Region Wise in 2021
Table Global Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Prostate Cancer Medicine Sales Volume by Type (2017-2022)
Table Global Prostate Cancer Medicine Sales Volume Market Share by Type (2017-2022)
Figure Global Prostate Cancer Medicine Sales Volume Market Share by Type in 2021
Table Global Prostate Cancer Medicine Revenue (Million USD) by Type (2017-2022)
Table Global Prostate Cancer Medicine Revenue Market Share by Type (2017-2022)
Figure Global Prostate Cancer Medicine Revenue Market Share by Type in 2021
Table Prostate Cancer Medicine Price by Type (2017-2022)
Figure Global Prostate Cancer Medicine Sales Volume and Growth Rate of LHRH Antagonists (2017-2022)
Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate of LHRH Antagonists (2017-2022)
Figure Global Prostate Cancer Medicine Sales Volume and Growth Rate of LHRH Analogs (2017-2022)
Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate of LHRH Analogs (2017-2022)
Figure Global Prostate Cancer Medicine Sales Volume and Growth Rate of Antiandrogens (2017-2022)
Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate of Antiandrogens (2017-2022)
Figure Global Prostate Cancer Medicine Sales Volume and Growth Rate of Pipeline Drugs for Hormonal Therapy (2017-2022)
Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate of Pipeline Drugs for Hormonal Therapy (2017-2022)
Table Global Prostate Cancer Medicine Consumption by Application (2017-2022)
Table Global Prostate Cancer Medicine Consumption Market Share by Application (2017-2022)
Table Global Prostate Cancer Medicine Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Prostate Cancer Medicine Consumption Revenue Market Share by Application (2017-2022)
Table Global Prostate Cancer Medicine Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Prostate Cancer Medicine Consumption and Growth Rate of Other (2017-2022)
Figure Global Prostate Cancer Medicine Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Prostate Cancer Medicine Price and Trend Forecast (2022-2027)
Figure USA Prostate Cancer Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Prostate Cancer Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Prostate Cancer Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Prostate Cancer Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Prostate Cancer Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Prostate Cancer Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Prostate Cancer Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Prostate Cancer Medicine Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Prostate Cancer Medicine Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Prostate Cancer Medicine Market Sales Volume Forecast, by Type
Table Global Prostate Cancer Medicine Sales Volume Market Share Forecast, by Type
Table Global Prostate Cancer Medicine Market Revenue (Million USD) Forecast, by Type
Table Global Prostate Cancer Medicine Revenue Market Share Forecast, by Type
Table Global Prostate Cancer Medicine Price Forecast, by Type
Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate of LHRH Antagonists (2022-2027)
Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate of LHRH Antagonists (2022-2027)
Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate of LHRH Analogs (2022-2027)
Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate of LHRH Analogs (2022-2027)
Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate of Antiandrogens (2022-2027)
Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate of Antiandrogens (2022-2027)
Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate of Pipeline Drugs for Hormonal Therapy (2022-2027)
Figure Global Prostate Cancer Medicine Revenue (Million USD) and Growth Rate of Pipeline Drugs for Hormonal Therapy (2022-2027)
Table Global Prostate Cancer Medicine Market Consumption Forecast, by Application
Table Global Prostate Cancer Medicine Consumption Market Share Forecast, by Application
Table Global Prostate Cancer Medicine Market Revenue (Million USD) Forecast, by Application
Table Global Prostate Cancer Medicine Revenue Market Share Forecast, by Application
Figure Global Prostate Cancer Medicine Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Prostate Cancer Medicine Consumption Value (Million USD) and Growth Rate of Other (2022-2027)
Figure Prostate Cancer Medicine Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Bristol Myers-Squibb Profile
Table Bristol Myers-Squibb Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol Myers-Squibb Prostate Cancer Medicine Sales Volume and Growth Rate
Figure Bristol Myers-Squibb Revenue (Million USD) Market Share 2017-2022
Table Bayer AG Profile
Table Bayer AG Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bayer AG Prostate Cancer Medicine Sales Volume and Growth Rate
Figure Bayer AG Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Prostate Cancer Medicine Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table Astellas Pharma Inc. Profile
Table Astellas Pharma Inc. Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Astellas Pharma Inc. Prostate Cancer Medicine Sales Volume and Growth Rate
Figure Astellas Pharma Inc. Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Prostate Cancer Medicine Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table Active Biotech Profile
Table Active Biotech Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Active Biotech Prostate Cancer Medicine Sales Volume and Growth Rate
Figure Active Biotech Revenue (Million USD) Market Share 2017-2022
Table Abbott Laboratories Profile
Table Abbott Laboratories Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbott Laboratories Prostate Cancer Medicine Sales Volume and Growth Rate
Figure Abbott Laboratories Revenue (Million USD) Market Share 2017-2022
Table Teva Pharmaceuticals Industries Ltd. Profile
Table Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Sales Volume and Growth Rate
Figure Teva Pharmaceuticals Industries Ltd. Revenue (Million USD) Market Share 2017-2022
Table Roche Holding AG Profile
Table Roche Holding AG Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Roche Holding AG Prostate Cancer Medicine Sales Volume and Growth Rate
Figure Roche Holding AG Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca plc Profile
Table AstraZeneca plc Prostate Cancer Medicine Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca plc Prostate Cancer Medicine Sales Volume and Growth Rate
Figure AstraZeneca plc Revenue (Million USD) Market Share 2017-2022


More Publications